Log in

Meet the 2025 Annual Conference Speakers

Additional information will be added as it is available.


Vijay Ramanan, MD, PhD - Mayo Clinic, Rochester
  • Dr. Ramanan is a Consultant and Associate Professor in the Department of Neurology and Division of Cognitive/Behavioral Neurology at the Mayo Clinic in Rochester. His clinical and research interests center on neurodegenerative diseases, particularly in relation to polygenic risk scores and blood biomarkers of disease. He is also the Director of the Alzheimer’s Disease Treatment Clinic and is involved in clinical trials for AD and related diseases.


Alberto Espay, MD, MSc, FAAN, FANA - University of Cincinnati
  • Dr. Alberto Espay is Professor and Endowed Chair of the James J. and Joan A. Gardner Center for Parkinson’s Disease at the University of Cincinnati. He has published over 380 peer-reviewed research articles, 40 book chapters and 10 books, including Common Movement Disorders Pitfalls, which received the Highly Commended BMA Medical Book Award in 2013, and Brain Fables, the Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer Them, coauthored with Parkinson patient and advocate Benjamin Stecher, selected by the Association of American Publishers for the PROSE Award honoring the best scholarly work in Neuroscience published in 2020. He has served as Chair of the Movement Disorders Section of the American Academy of Neurology, Associate Editor of the Movement Disorders journal, and on the Executive Committee of the Parkinson Study Group. Among other honors, he has received the Cincinnati Business Courier’s Health Care Hero award, the Spanish Society of Neurology’s Cotzias award, and honorary membership in the Mexican Academy of Neurology. His 2022 TEDx presentation, “Parkinson’s and Alzheimer’s: The Solution in Sight,” was selected from more than 12,000 global entries for two 2023 Telly Awards, which honor excellence in video and television across all screens. He currently serves as President of the Pan-American Section of the International Parkinson and Movement Disorders Society and directs the first biomarker study of aging (CCBPstudy.com), designed to match people with neurodegenerative disorders to available therapies from which they are most biologically suitable to benefit, regardless of clinical diagnoses.


Kristen Seaborg, MD - UW Madison
  • Kristin Seaborg is an assistant professor of pediatric neurology and sleep medicine at the University of Wisconsin. As a former pediatrician and current pediatric neurologist, she has seen the impact that sleep disorders can have on many aspects of a child’s overall health and wellbeing.


Gregory Rozansky, MD - Medical College of WI
  • Originally from Montreal, Canada, and came to Milwaukee for residency training in Neurology at the Medical College of Wisconsin in 2014. I then completed my Neurocritical Care fellowship training at the Medical College of Wisconsin. I now serve as faculty in the Neurosciences ICU at MCW, where I am the Program Director of Neurocritical Care Fellowship program, an ACGME, UCNS and CAST accredited program. At Froedtert Hospital I am the associate director of the Neurosciences ICU as well as the patient safety and quality officer for the department of Neurology. I serve as the Primary investigator for a number of multi-center trials. My clinical interests include Penetrating Brain Injuries, prognostication in Traumatic Brain Injury and the use of point-of-care critical care ultrasonography for patients suffering from neurological diseases.


Jonathan Mietchen, PhD - UW Madison
  • Jonathan Mietchen is a pediatric neuropsychologist and an assistant professor in the Department of Neurology at the University of Wisconsin School of Medicine and Public Health. Jonathan specializes in cognitive and neuropsychological evaluations for children and adolescents with medical disorders, developmental delays. He staffs the Brain Care Clinic at the Waisman Center – a clinic devoted to the evaluation of pediatric concussion – where he provides neuropsychological assessment and treatment recommendations to promote concussion recovery.
Powered by Wild Apricot Membership Software